Roche and partner Klinrisk have picked up a CE-mark in the EU for an AI-based tool that can be used to predict renal function decline in patients with chronic kidney disease (CKD). The algorithm will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback